Industry Research Reports

Home > Reports > Medical Care > Pharmaceutical Fine Chemicals - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Pharmaceutical Fine Chemicals - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-24

Pages: 135 Pages

Report ld: 2336806

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Pharmaceutical fine chemicals can be broadly defined as the set of products—intermediates and finished API, or active pharmaceutical ingredients—as well as related services like process development and optimization associated with the access by pharmaceutical companies to the drug substance (API) throughout the product life cycle excluding pre-clinical development.

The global market for Pharmaceutical Fine Chemicals was estimated to be worth US$ 109680 million in 2023 and is forecast to a readjusted size of US$ 155620 million by 2030 with a CAGR of 5.2% during the forecast period 2024-2030

Pharmaceutical Fine Chemicals Market Size

M= millions and B=billions

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Fine Chemicals, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharmaceutical Fine Chemicals by region & country, by Type, and by Application.

The Pharmaceutical Fine Chemicals market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Fine Chemicals.

Market Segmentation

Report Metric
Details
Report Title
Pharmaceutical Fine Chemicals - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 155620 million
CAGR(2024-2030)
5.2%
Market Size Available for Years
2019-2030
Global Pharmaceutical Fine Chemicals Companies Covered
Lonza, CML, FIS, Hovione, Bachem, Helsinn Advanced Synthesis, Umicore, Sifavitor (Infa Group), Chemo, W.R. Grace, Kenko Corporation, Albemarle Corporation, Denisco Chemicals, Chemada Fine Chemicals, Syntor Fine Chemicals, Johnson Matthey Fine Chemicals
Global Pharmaceutical Fine Chemicals Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmaceutical Fine Chemicals Market, Segment by Type
Large Molecules

Small Molecules
Global Pharmaceutical Fine Chemicals Market, Segment by Application
Third Party Vendors

Emerging Pharmaceutical Companies

Established Pharmaceutical Companies
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharmaceutical Fine Chemicals manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Pharmaceutical Fine Chemicals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Pharmaceutical Fine Chemicals in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Pharmaceutical Fine Chemicals Product Introduction
    1.2 Global Pharmaceutical Fine Chemicals Market Size Forecast
    1.3 Pharmaceutical Fine Chemicals Market Trends & Drivers
        1.3.1 Pharmaceutical Fine Chemicals Industry Trends
        1.3.2 Pharmaceutical Fine Chemicals Market Drivers & Opportunity
        1.3.3 Pharmaceutical Fine Chemicals Market Challenges
        1.3.4 Pharmaceutical Fine Chemicals Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Pharmaceutical Fine Chemicals Players Revenue Ranking (2023)
    2.2 Global Pharmaceutical Fine Chemicals Revenue by Company (2019-2024)
    2.3 Key Companies Pharmaceutical Fine Chemicals Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Pharmaceutical Fine Chemicals Product Offered
    2.5 Key Companies Time to Begin Mass Production of Pharmaceutical Fine Chemicals
    2.6 Pharmaceutical Fine Chemicals Market Competitive Analysis
        2.6.1 Pharmaceutical Fine Chemicals Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Pharmaceutical Fine Chemicals Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Fine Chemicals as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Large Molecules
        3.1.2 Small Molecules
    3.2 Global Pharmaceutical Fine Chemicals Sales Value by Type
        3.2.1 Global Pharmaceutical Fine Chemicals Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Pharmaceutical Fine Chemicals Sales Value, by Type (2019-2030)
        3.2.3 Global Pharmaceutical Fine Chemicals Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Third Party Vendors
        4.1.2 Emerging Pharmaceutical Companies
        4.1.3 Established Pharmaceutical Companies
    4.2 Global Pharmaceutical Fine Chemicals Sales Value by Application
        4.2.1 Global Pharmaceutical Fine Chemicals Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Pharmaceutical Fine Chemicals Sales Value, by Application (2019-2030)
        4.2.3 Global Pharmaceutical Fine Chemicals Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Pharmaceutical Fine Chemicals Sales Value by Region
        5.1.1 Global Pharmaceutical Fine Chemicals Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Pharmaceutical Fine Chemicals Sales Value by Region (2019-2024)
        5.1.3 Global Pharmaceutical Fine Chemicals Sales Value by Region (2025-2030)
        5.1.4 Global Pharmaceutical Fine Chemicals Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Pharmaceutical Fine Chemicals Sales Value, 2019-2030
        5.2.2 North America Pharmaceutical Fine Chemicals Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Pharmaceutical Fine Chemicals Sales Value, 2019-2030
        5.3.2 Europe Pharmaceutical Fine Chemicals Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Pharmaceutical Fine Chemicals Sales Value, 2019-2030
        5.4.2 Asia Pacific Pharmaceutical Fine Chemicals Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Pharmaceutical Fine Chemicals Sales Value, 2019-2030
        5.5.2 South America Pharmaceutical Fine Chemicals Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Pharmaceutical Fine Chemicals Sales Value, 2019-2030
        5.6.2 Middle East & Africa Pharmaceutical Fine Chemicals Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Pharmaceutical Fine Chemicals Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Pharmaceutical Fine Chemicals Sales Value
    6.3 United States
        6.3.1 United States Pharmaceutical Fine Chemicals Sales Value, 2019-2030
        6.3.2 United States Pharmaceutical Fine Chemicals Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Pharmaceutical Fine Chemicals Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Pharmaceutical Fine Chemicals Sales Value, 2019-2030
        6.4.2 Europe Pharmaceutical Fine Chemicals Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Pharmaceutical Fine Chemicals Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Pharmaceutical Fine Chemicals Sales Value, 2019-2030
        6.5.2 China Pharmaceutical Fine Chemicals Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Pharmaceutical Fine Chemicals Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Pharmaceutical Fine Chemicals Sales Value, 2019-2030
        6.6.2 Japan Pharmaceutical Fine Chemicals Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Pharmaceutical Fine Chemicals Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Pharmaceutical Fine Chemicals Sales Value, 2019-2030
        6.7.2 South Korea Pharmaceutical Fine Chemicals Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Pharmaceutical Fine Chemicals Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Pharmaceutical Fine Chemicals Sales Value, 2019-2030
        6.8.2 Southeast Asia Pharmaceutical Fine Chemicals Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Pharmaceutical Fine Chemicals Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Pharmaceutical Fine Chemicals Sales Value, 2019-2030
        6.9.2 India Pharmaceutical Fine Chemicals Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Pharmaceutical Fine Chemicals Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Lonza
        7.1.1 Lonza Profile
        7.1.2 Lonza Main Business
        7.1.3 Lonza Pharmaceutical Fine Chemicals Products, Services and Solutions
        7.1.4 Lonza Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2019-2024)
        7.1.5 Lonza Recent Developments
    7.2 CML
        7.2.1 CML Profile
        7.2.2 CML Main Business
        7.2.3 CML Pharmaceutical Fine Chemicals Products, Services and Solutions
        7.2.4 CML Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2019-2024)
        7.2.5 CML Recent Developments
    7.3 FIS
        7.3.1 FIS Profile
        7.3.2 FIS Main Business
        7.3.3 FIS Pharmaceutical Fine Chemicals Products, Services and Solutions
        7.3.4 FIS Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2019-2024)
        7.3.5 Hovione Recent Developments
    7.4 Hovione
        7.4.1 Hovione Profile
        7.4.2 Hovione Main Business
        7.4.3 Hovione Pharmaceutical Fine Chemicals Products, Services and Solutions
        7.4.4 Hovione Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2019-2024)
        7.4.5 Hovione Recent Developments
    7.5 Bachem
        7.5.1 Bachem Profile
        7.5.2 Bachem Main Business
        7.5.3 Bachem Pharmaceutical Fine Chemicals Products, Services and Solutions
        7.5.4 Bachem Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2019-2024)
        7.5.5 Bachem Recent Developments
    7.6 Helsinn Advanced Synthesis
        7.6.1 Helsinn Advanced Synthesis Profile
        7.6.2 Helsinn Advanced Synthesis Main Business
        7.6.3 Helsinn Advanced Synthesis Pharmaceutical Fine Chemicals Products, Services and Solutions
        7.6.4 Helsinn Advanced Synthesis Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2019-2024)
        7.6.5 Helsinn Advanced Synthesis Recent Developments
    7.7 Umicore
        7.7.1 Umicore Profile
        7.7.2 Umicore Main Business
        7.7.3 Umicore Pharmaceutical Fine Chemicals Products, Services and Solutions
        7.7.4 Umicore Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2019-2024)
        7.7.5 Umicore Recent Developments
    7.8 Sifavitor (Infa Group)
        7.8.1 Sifavitor (Infa Group) Profile
        7.8.2 Sifavitor (Infa Group) Main Business
        7.8.3 Sifavitor (Infa Group) Pharmaceutical Fine Chemicals Products, Services and Solutions
        7.8.4 Sifavitor (Infa Group) Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2019-2024)
        7.8.5 Sifavitor (Infa Group) Recent Developments
    7.9 Chemo
        7.9.1 Chemo Profile
        7.9.2 Chemo Main Business
        7.9.3 Chemo Pharmaceutical Fine Chemicals Products, Services and Solutions
        7.9.4 Chemo Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2019-2024)
        7.9.5 Chemo Recent Developments
    7.10 W.R. Grace
        7.10.1 W.R. Grace Profile
        7.10.2 W.R. Grace Main Business
        7.10.3 W.R. Grace Pharmaceutical Fine Chemicals Products, Services and Solutions
        7.10.4 W.R. Grace Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2019-2024)
        7.10.5 W.R. Grace Recent Developments
    7.11 Kenko Corporation
        7.11.1 Kenko Corporation Profile
        7.11.2 Kenko Corporation Main Business
        7.11.3 Kenko Corporation Pharmaceutical Fine Chemicals Products, Services and Solutions
        7.11.4 Kenko Corporation Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2019-2024)
        7.11.5 Kenko Corporation Recent Developments
    7.12 Albemarle Corporation
        7.12.1 Albemarle Corporation Profile
        7.12.2 Albemarle Corporation Main Business
        7.12.3 Albemarle Corporation Pharmaceutical Fine Chemicals Products, Services and Solutions
        7.12.4 Albemarle Corporation Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2019-2024)
        7.12.5 Albemarle Corporation Recent Developments
    7.13 Denisco Chemicals
        7.13.1 Denisco Chemicals Profile
        7.13.2 Denisco Chemicals Main Business
        7.13.3 Denisco Chemicals Pharmaceutical Fine Chemicals Products, Services and Solutions
        7.13.4 Denisco Chemicals Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2019-2024)
        7.13.5 Denisco Chemicals Recent Developments
    7.14 Chemada Fine Chemicals
        7.14.1 Chemada Fine Chemicals Profile
        7.14.2 Chemada Fine Chemicals Main Business
        7.14.3 Chemada Fine Chemicals Pharmaceutical Fine Chemicals Products, Services and Solutions
        7.14.4 Chemada Fine Chemicals Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2019-2024)
        7.14.5 Chemada Fine Chemicals Recent Developments
    7.15 Syntor Fine Chemicals
        7.15.1 Syntor Fine Chemicals Profile
        7.15.2 Syntor Fine Chemicals Main Business
        7.15.3 Syntor Fine Chemicals Pharmaceutical Fine Chemicals Products, Services and Solutions
        7.15.4 Syntor Fine Chemicals Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2019-2024)
        7.15.5 Syntor Fine Chemicals Recent Developments
    7.16 Johnson Matthey Fine Chemicals
        7.16.1 Johnson Matthey Fine Chemicals Profile
        7.16.2 Johnson Matthey Fine Chemicals Main Business
        7.16.3 Johnson Matthey Fine Chemicals Pharmaceutical Fine Chemicals Products, Services and Solutions
        7.16.4 Johnson Matthey Fine Chemicals Pharmaceutical Fine Chemicals Revenue (US$ Million) & (2019-2024)
        7.16.5 Johnson Matthey Fine Chemicals Recent Developments

 8 Industry Chain Analysis
    8.1 Pharmaceutical Fine Chemicals Industrial Chain
    8.2 Pharmaceutical Fine Chemicals Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Pharmaceutical Fine Chemicals Sales Model
        8.5.2 Sales Channel
        8.5.3 Pharmaceutical Fine Chemicals Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Pharmaceutical Fine Chemicals Market Trends
    Table 2. Pharmaceutical Fine Chemicals Market Drivers & Opportunity
    Table 3. Pharmaceutical Fine Chemicals Market Challenges
    Table 4. Pharmaceutical Fine Chemicals Market Restraints
    Table 5. Global Pharmaceutical Fine Chemicals Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Pharmaceutical Fine Chemicals Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Pharmaceutical Fine Chemicals Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Pharmaceutical Fine Chemicals Product Type
    Table 9. Key Companies Time to Begin Mass Production of Pharmaceutical Fine Chemicals
    Table 10. Global Pharmaceutical Fine Chemicals Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Fine Chemicals as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Pharmaceutical Fine Chemicals Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Pharmaceutical Fine Chemicals Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Pharmaceutical Fine Chemicals Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Pharmaceutical Fine Chemicals Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Pharmaceutical Fine Chemicals Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Pharmaceutical Fine Chemicals Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Pharmaceutical Fine Chemicals Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Pharmaceutical Fine Chemicals Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Pharmaceutical Fine Chemicals Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Pharmaceutical Fine Chemicals Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Pharmaceutical Fine Chemicals Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Pharmaceutical Fine Chemicals Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Pharmaceutical Fine Chemicals Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Pharmaceutical Fine Chemicals Sales Value by Region (2019-2024) & (%)
    Table 27. Global Pharmaceutical Fine Chemicals Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Pharmaceutical Fine Chemicals Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Pharmaceutical Fine Chemicals Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Pharmaceutical Fine Chemicals Sales Value, (2025-2030) & (US$ Million)
    Table 31. Lonza Basic Information List
    Table 32. Lonza Description and Business Overview
    Table 33. Lonza Pharmaceutical Fine Chemicals Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Pharmaceutical Fine Chemicals Business of Lonza (2019-2024)
    Table 35. Lonza Recent Developments
    Table 36. CML Basic Information List
    Table 37. CML Description and Business Overview
    Table 38. CML Pharmaceutical Fine Chemicals Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Pharmaceutical Fine Chemicals Business of CML (2019-2024)
    Table 40. CML Recent Developments
    Table 41. FIS Basic Information List
    Table 42. FIS Description and Business Overview
    Table 43. FIS Pharmaceutical Fine Chemicals Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Pharmaceutical Fine Chemicals Business of FIS (2019-2024)
    Table 45. FIS Recent Developments
    Table 46. Hovione Basic Information List
    Table 47. Hovione Description and Business Overview
    Table 48. Hovione Pharmaceutical Fine Chemicals Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Pharmaceutical Fine Chemicals Business of Hovione (2019-2024)
    Table 50. Hovione Recent Developments
    Table 51. Bachem Basic Information List
    Table 52. Bachem Description and Business Overview
    Table 53. Bachem Pharmaceutical Fine Chemicals Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Pharmaceutical Fine Chemicals Business of Bachem (2019-2024)
    Table 55. Bachem Recent Developments
    Table 56. Helsinn Advanced Synthesis Basic Information List
    Table 57. Helsinn Advanced Synthesis Description and Business Overview
    Table 58. Helsinn Advanced Synthesis Pharmaceutical Fine Chemicals Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Pharmaceutical Fine Chemicals Business of Helsinn Advanced Synthesis (2019-2024)
    Table 60. Helsinn Advanced Synthesis Recent Developments
    Table 61. Umicore Basic Information List
    Table 62. Umicore Description and Business Overview
    Table 63. Umicore Pharmaceutical Fine Chemicals Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Pharmaceutical Fine Chemicals Business of Umicore (2019-2024)
    Table 65. Umicore Recent Developments
    Table 66. Sifavitor (Infa Group) Basic Information List
    Table 67. Sifavitor (Infa Group) Description and Business Overview
    Table 68. Sifavitor (Infa Group) Pharmaceutical Fine Chemicals Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Pharmaceutical Fine Chemicals Business of Sifavitor (Infa Group) (2019-2024)
    Table 70. Sifavitor (Infa Group) Recent Developments
    Table 71. Chemo Basic Information List
    Table 72. Chemo Description and Business Overview
    Table 73. Chemo Pharmaceutical Fine Chemicals Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Pharmaceutical Fine Chemicals Business of Chemo (2019-2024)
    Table 75. Chemo Recent Developments
    Table 76. W.R. Grace Basic Information List
    Table 77. W.R. Grace Description and Business Overview
    Table 78. W.R. Grace Pharmaceutical Fine Chemicals Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Pharmaceutical Fine Chemicals Business of W.R. Grace (2019-2024)
    Table 80. W.R. Grace Recent Developments
    Table 81. Kenko Corporation Basic Information List
    Table 82. Kenko Corporation Description and Business Overview
    Table 83. Kenko Corporation Pharmaceutical Fine Chemicals Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Pharmaceutical Fine Chemicals Business of Kenko Corporation (2019-2024)
    Table 85. Kenko Corporation Recent Developments
    Table 86. Albemarle Corporation Basic Information List
    Table 87. Albemarle Corporation Description and Business Overview
    Table 88. Albemarle Corporation Pharmaceutical Fine Chemicals Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Pharmaceutical Fine Chemicals Business of Albemarle Corporation (2019-2024)
    Table 90. Albemarle Corporation Recent Developments
    Table 91. Denisco Chemicals Basic Information List
    Table 92. Denisco Chemicals Description and Business Overview
    Table 93. Denisco Chemicals Pharmaceutical Fine Chemicals Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Pharmaceutical Fine Chemicals Business of Denisco Chemicals (2019-2024)
    Table 95. Denisco Chemicals Recent Developments
    Table 96. Chemada Fine Chemicals Basic Information List
    Table 97. Chemada Fine Chemicals Description and Business Overview
    Table 98. Chemada Fine Chemicals Pharmaceutical Fine Chemicals Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Pharmaceutical Fine Chemicals Business of Chemada Fine Chemicals (2019-2024)
    Table 100. Chemada Fine Chemicals Recent Developments
    Table 101. Syntor Fine Chemicals Basic Information List
    Table 102. Syntor Fine Chemicals Description and Business Overview
    Table 103. Syntor Fine Chemicals Pharmaceutical Fine Chemicals Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Pharmaceutical Fine Chemicals Business of Syntor Fine Chemicals (2019-2024)
    Table 105. Syntor Fine Chemicals Recent Developments
    Table 106. Johnson Matthey Fine Chemicals Basic Information List
    Table 107. Johnson Matthey Fine Chemicals Description and Business Overview
    Table 108. Johnson Matthey Fine Chemicals Pharmaceutical Fine Chemicals Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Pharmaceutical Fine Chemicals Business of Johnson Matthey Fine Chemicals (2019-2024)
    Table 110. Johnson Matthey Fine Chemicals Recent Developments
    Table 111. Key Raw Materials Lists
    Table 112. Raw Materials Key Suppliers Lists
    Table 113. Pharmaceutical Fine Chemicals Downstream Customers
    Table 114. Pharmaceutical Fine Chemicals Distributors List
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
    Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Pharmaceutical Fine Chemicals Product Picture
    Figure 2. Global Pharmaceutical Fine Chemicals Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Pharmaceutical Fine Chemicals Sales Value (2019-2030) & (US$ Million)
    Figure 4. Pharmaceutical Fine Chemicals Report Years Considered
    Figure 5. Global Pharmaceutical Fine Chemicals Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Pharmaceutical Fine Chemicals Revenue in 2023
    Figure 7. Pharmaceutical Fine Chemicals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Large Molecules Picture
    Figure 9. Small Molecules Picture
    Figure 10. Global Pharmaceutical Fine Chemicals Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Pharmaceutical Fine Chemicals Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Third Party Vendors
    Figure 13. Product Picture of Emerging Pharmaceutical Companies
    Figure 14. Product Picture of Established Pharmaceutical Companies
    Figure 15. Global Pharmaceutical Fine Chemicals Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Pharmaceutical Fine Chemicals Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Pharmaceutical Fine Chemicals Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Pharmaceutical Fine Chemicals Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Pharmaceutical Fine Chemicals Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Pharmaceutical Fine Chemicals Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Pharmaceutical Fine Chemicals Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Pharmaceutical Fine Chemicals Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Pharmaceutical Fine Chemicals Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Pharmaceutical Fine Chemicals Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Pharmaceutical Fine Chemicals Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Pharmaceutical Fine Chemicals Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Pharmaceutical Fine Chemicals Sales Value (%), (2019-2030)
    Figure 28. United States Pharmaceutical Fine Chemicals Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Pharmaceutical Fine Chemicals Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Pharmaceutical Fine Chemicals Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Pharmaceutical Fine Chemicals Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Pharmaceutical Fine Chemicals Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Pharmaceutical Fine Chemicals Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Pharmaceutical Fine Chemicals Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Pharmaceutical Fine Chemicals Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Pharmaceutical Fine Chemicals Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Pharmaceutical Fine Chemicals Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Pharmaceutical Fine Chemicals Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Pharmaceutical Fine Chemicals Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Pharmaceutical Fine Chemicals Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Pharmaceutical Fine Chemicals Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Pharmaceutical Fine Chemicals Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Pharmaceutical Fine Chemicals Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Pharmaceutical Fine Chemicals Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Pharmaceutical Fine Chemicals Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Pharmaceutical Fine Chemicals Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Pharmaceutical Fine Chemicals Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Pharmaceutical Fine Chemicals Sales Value by Application (%), 2023 VS 2030
    Figure 49. Pharmaceutical Fine Chemicals Industrial Chain
    Figure 50. Pharmaceutical Fine Chemicals Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation

Pharmaceutical fine chemicals can be broadly defined as the set of products—intermediates and finished API, or active pharmaceutical ingredients—as well as related services like process development and optimization associated with the access by pharmaceutical companies to the drug substance (API) throughout the product life cycle excluding pre-clinical development.

The global market for Pharmaceutical Fine Chemicals was estimated to be worth US$ 109680 million in 2023 and is forecast to a readjusted size of US$ 155620 million by 2030 with a CAGR of 5.2% during the forecast period 2024-2030

Market Segmentation

Industry: Medical Care

Published: 2024-01-24

Pages: 135 Pages

Report ld: 2336806

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3950.00

Multi Users License

USD 5925.00

Corporate Users License

USD 7900.00

/uploads/payment/payIcon/masterCard-01.svg

/uploads/payment/payIcon/american-express-01.svg

/uploads/payment/payIcon/diners-club-01.svg

/uploads/payment/payIcon/discover-4-01.svg

Add to Cart

Buy Now

A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.

In-depth research on key industry players and analysis of production and sales operations.

Objective forecasts of future trends in the industry.

Speak To Our Analyst >>

WHAT QYRESEARCH OFFER?